PHG
Koninklijke Philips N.V.NYSEHealthcare$27.11-0.66%ClosedMarket Cap: $25.99B
As of 2026-04-06
Valuation
P/E (TTM)
29.04
PEG
0.13
P/B
2.05
P/S
1.26
EV/EBITDA
10.24
DCF Value
$59.07
FCF Yield
3.1%
Div Yield
3.6%
Margins & Returns
Gross Margin
45.2%
Operating Margin
8.6%
Net Margin
5.0%
ROE
8.2%
ROA
3.3%
ROIC
5.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $5.10B | 44.9% | $540.0M | $395.0M | $0.41 | — |
| FY 2025 | $17.83B | 45.2% | $1.42B | $895.0M | $0.93 | $0.89 |
| Q3 2025 | $4.30B | 44.4% | $330.0M | $184.0M | $0.19 | — |
| Q2 2025 | $4.34B | 46.4% | $400.0M | $240.0M | $0.25 | $0.89 |
| Q1 2025 | $4.10B | 45.1% | $154.0M | $76.0M | $0.08 | — |
| Q4 2024 | $5.04B | 38.9% | $199.0M | $-335.0M | $-0.36 | — |
| FY 2024 | $18.02B | 43.1% | $529.0M | $-702.0M | $-0.75 | $0.95 |
| Q3 2024 | $4.38B | 45.8% | $337.0M | $181.0M | $0.20 | — |
| Q2 2024 | $4.46B | 44.6% | $816.0M | $451.0M | $0.48 | $0.95 |
| Q1 2024 | $4.14B | 43.9% | $-824.0M | $-999.0M | $-1.07 | — |
| Q4 2023 | $5.06B | 35.5% | $24.0M | $39.0M | $0.04 | — |
| FY 2023 | $18.17B | 41.0% | $-115.0M | $-466.0M | $-0.49 | — |